Bank of America
NKGNW

Bank of America’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Bank of America’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,000
Closed -$11K – 8482
2022
Q1 		$11K Hold
20,000
– – ﹤0.01% 7721
2021
Q4 		$23K Buy
+20,000
New +$20.3K ﹤0.01% 7479

Other funds holding NKGNW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.62% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bank of America's NKGNW Position: Q2 2022 in Review

Bank of America sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q2 2022, closing a stake of 20,000 shares — an estimated $11K sold.

Bank of America first reported a position in NKGNW in Q4 2021 and held it in 2 quarters. The position peaked at $23K in Q4 2021. 35 funds tracked by Wall St. Rank hold NKGNW as of Q2 2022.

  • Bank of America reported no remaining NKGen Biotech, Inc. Warrants position as of Q2 2022 after selling out during the quarter.
  • Bank of America sold 20,000 NKGen Biotech, Inc. Warrants shares in Q2 2022, an estimated $11K.
  • Bank of America first reported a position in NKGen Biotech, Inc. Warrants in Q4 2021 and held it in 2 quarters.
  • Bank of America's NKGen Biotech, Inc. Warrants position peaked at $23K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q2 2022.

Based on Bank of America's 13F filing for Q2 2022, filed 12 Aug 2022.